A citation-based method for searching scientific literature

Charles E Geyer, John Forster, Deborah Lindquist, Stephen Chan, C Gilles Romieu, Tadeusz Pienkowski, Agnieszka Jagiello-Gruszfeld, John Crown, Arlene Chan, Bella Kaufman, Dimosthenis Skarlos, Mario Campone, Neville Davidson, Mark Berger, Cristina Oliva, Stephen D Rubin, Steven Stein, David Cameron. N Engl J Med 2006
Times Cited: 2289



Sherene Loi, Anita Giobbie-Hurder, Andrea Gombos, Thomas Bachelot, Rina Hui, Giuseppe Curigliano, Mario Campone, Laura Biganzoli, Hervé Bonnefoi, Guy Jerusalem, Rupert Bartsch, Manuela Rabaglio-Poretti, Roswitha Kammler, Rudolf Maibach, Mark J Smyth, Angelo Di Leo, Marco Colleoni, Giuseppe Viale, Meredith M Regan, Fabrice André. Lancet Oncol 2019
Times Cited: 192




List of shared articles



Times cited

Updated Austrian treatment algorithm in HER2+ metastatic breast cancer.
Rupert Bartsch, Simon Peter Gampenrieder, Gabriel Rinnerthaler, Edgar Petru, Daniel Egle, Andreas Petzer, Marija Balic, Ursula Pluschnig, Thamer Sliwa, Christian Singer. Wien Klin Wochenschr 2022
0

Anti-HER2 therapy in metastatic breast cancer: many choices and future directions.
Carrie S Wynn, Shou-Ching Tang. Cancer Metastasis Rev 2022
1


Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease.
Matthew N Mills, Whitney King, Aixa Soyano, Yolanda Pina, Brian J Czerniecki, Peter A Forsyth, Hatem Soliman, Hyo S Han, Kamran A Ahmed. J Neurooncol 2022
0


[New therapeutic strategies in HER2-positive breast cancer].
Benoîte Mery, Philippe Toussaint, Pierre-Etienne Heudel, Armelle Dufresne, Mélodie Carbonnaux, Hélène Vanacker, Thomas Bachelot, Olivier Trédan. Bull Cancer 2021
0

Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer.
Mohamad Adham Salkeni, Wajeeha Rizvi, Kyaw Hein, Gerald M Higa. Breast Cancer (Dove Med Press) 2021
0

The management of HER2-positive early breast cancer: Current and future therapies.
Julia Chen, Maree Colosimo, Elgene Lim. Asia Pac J Clin Oncol 2021
3